share_log

12 Health Care Stocks Moving In Tuesday's After-Market Session

Benzinga ·  Apr 3 04:31

Gainers

  • OneMedNet (NASDAQ:ONMD) shares moved upwards by 75.9% to $1.39 during Tuesday's after-market session. The market value of their outstanding shares is at $44.8 million.
  • Aesthetic Medical Intl (NASDAQ:AIH) shares rose 43.48% to $0.49. The market value of their outstanding shares is at $23.1 million.
  • Sight Sciences (NASDAQ:SGHT) shares rose 20.77% to $6.57. The market value of their outstanding shares is at $325.5 million.
  • Inspire Veterinary (NASDAQ:IVP) stock increased by 16.59% to $0.05. The market value of their outstanding shares is at $1.7 million.
  • GlycoMimetics (NASDAQ:GLYC) stock rose 6.41% to $3.15. The market value of their outstanding shares is at $203.0 million. As per the news, the Q4 earnings report came out 4 days ago.
  • Bionomics (NASDAQ:BNOX) stock rose 6.01% to $1.05. The market value of their outstanding shares is at $11.2 million.

Losers

  • Enveric Biosciences (NASDAQ:ENVB) stock decreased by 14.1% to $0.98 during Tuesday's after-market session. The market value of their outstanding shares is at $7.1 million.
  • Acorda Therapeutics (NASDAQ:ACOR) stock fell 12.0% to $2.2. The market value of their outstanding shares is at $2.7 million. As per the news, the Q4 earnings report came out yesterday.
  • Imunon (NASDAQ:IMNN) shares declined by 7.43% to $1.62. The market value of their outstanding shares is at $15.2 million. As per the press release, Q4 earnings came out 3 days ago.
  • Mira Pharmaceuticals (NASDAQ:MIRA) shares decreased by 6.55% to $1.0. The market value of their outstanding shares is at $14.7 million. As per the press release, Q4 earnings came out yesterday.
  • Cyclo Therapeutics (NASDAQ:CYTH) shares fell 6.17% to $1.37. The market value of their outstanding shares is at $39.3 million.
  • Cutera (NASDAQ:CUTR) shares decreased by 4.9% to $1.36. The market value of their outstanding shares is at $27.1 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment